TCM
NEO icon

Timpani Capital Management’s NeoGenomics NEO Stock Holding History

Timpani Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-202,133
Closed -$1.73M – 113
2016
Q4 		$1.73M Sell
202,133
-43,720
-18% -$375K 0.72% 61
2016
Q3 		$2.02M Buy
245,853
+37,339
+18% +$313K 0.8% 52
2016
Q2 		$1.68M Buy
208,514
+40,308
+24% +$323K 0.71% 58
2016
Q1 		$1.13M Buy
+168,206
New +$1.11M 0.48% 75

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Timpani Capital Management's NEO Position: Q1 2017 in Review

Timpani Capital Management sold out of NeoGenomics (NEO) in Q1 2017, closing a stake of 202,133 shares — an estimated $1.73M sold.

Timpani Capital Management first reported a position in NEO in Q1 2016 and held it in 4 quarters. The position peaked at $2.02M in Q3 2016. 143 funds tracked by Wall St. Rank hold NEO as of Q1 2017.

  • Timpani Capital Management reported no remaining NeoGenomics position as of Q1 2017 after selling out during the quarter.
  • Timpani Capital Management sold 202,133 NeoGenomics shares in Q1 2017, an estimated $1.73M.
  • Timpani Capital Management first reported a position in NeoGenomics in Q1 2016 and held it in 4 quarters.
  • Timpani Capital Management's NeoGenomics position peaked at $2.02M in Q3 2016.
  • 143 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2017.

Based on Timpani Capital Management's 13F filing for Q1 2017, filed 12 May 2017.